Insider sells 150,000 shares of $CCCS, view remarks

In recent insider trading news, JOHN PAGE GOODSON, the See Remarks of $CCCS, conducted a significant sale by selling 150,000 shares of the company on 09-17-2025, resulting in an estimated value of $1,438,665. According to a recent SEC filing, this transaction accounted for roughly 48.8% of their shares in this stock class, leaving them with a remaining ownership of 157,478 shares of this particular $CCCS stock.

Over the past 6 months, $CCCS insiders have engaged in 26 transactions involving $CCCS stock. Out of these trades, 2 were purchases, while 24 were sales. Among the insider selling activities, notable individuals like INTERNATIONAL, L.P. ADVENT, LAUREN YOUNG, and ERIC WEI have each made 6 sales, totaling 60,000,000 shares each, with estimated values of $568,545,000. In contrast, JOHN PAGE GOODSON conducted 2 sales, selling 192,531 shares for around $1,855,098. On the purchasing side, TIMOTHY A WELSH and CRESCENZO NEIL E. DE each acquired 100,000 shares for an estimated $902,840 and $853,560, respectively.

Additionally, EILEEN SCHLOSS and RODNEY CHRISTO, the Chief Accounting Officer, both made 2 sales transactions each, selling 61,533 shares and 11,148 shares, respectively, for estimated amounts of $542,124 and $105,238.

In hedge fund activity related to $CCCS, there have been significant changes in institutional investors’ positions within the last quarter. Out of 208 institutional investors, 201 reduced their stake in $CCCS stock, while 7 increased their holdings. Noteworthy changes involve ADVENT INTERNATIONAL, L.P. removing 30,000,000 shares (-30.8%) from their portfolio, with an estimated value of $282,300,000. In contrast, PRICE T ROWE ASSOCIATES INC /MD/ added 15,613,026 shares (+228.7%), valued at around $146,918,574. POINTSTATE CAPITAL LP also saw an increase in their position by adding 10,093,001 shares (inf%). Among the reductions, T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 8,122,820 shares (-11.1%) from their portfolio, worth an estimated $76,435,736.

Regarding analyst ratings and price targets for $CCCS, Wall Street analysts have issued varying reports in recent months. While 3 firms issued buy ratings on the stock, 1 firm issued a sell rating. Notable recommendations include Barrington Research with an “Outperform” rating, and JP Morgan with an “Underweight” rating. Analysts have also assigned target prices for $CCCS, with a median target of $11.5. Among the recent targets set by analysts, John Barnidge and Gary Prestopino set target prices of $10.0 and $14.0, respectively. Saket Kalia and Alexei Gogolev have also set targets of $12.0 and $10.0, respectively.

It’s important to note that this information is not financial advice and readers should refer to Quiver Quantitative’s disclaimers for full details.